Study unpicks gene changes behind breast cancer

LONDON (Reuters) – Scientists have mapped the complete genetic codes of 21 breast cancers and created a catalogue of the mutations that accumulate in breast cells, raising hopes that the disease may be able to be spotted earlier and treated more effectively in future. The research, the first of its kind, untangles the genetic history of how cancer evolves, allowing scientists to identify mutational patterns that fuel the growth of breast tumors, and start to work out the processes behind them. …

More here:
Study unpicks gene changes behind breast cancer

 
 
 
 
 
 
 
 
 
 

J&J drug shows promise in high-risk prostate cancer

(Reuters) – Adding Johnson & Johnson’s advanced prostate cancer drug, Zytiga, to hormone therapy before surgery has been shown for the first time to eradicate tumors in some men with high-risk forms of the disease. The mid-stage trial found that six months of treatment with the combination therapy completely or nearly eliminated the cancer in a third of patients, all of whom had localized, aggressive cancer. ..

Read the original:
J&J drug shows promise in high-risk prostate cancer